Literature DB >> 17931627

Early-onset Alzheimer's disease with a de novo mutation in the presenilin 1 gene.

M P Golan1, M Styczyńska, K Jóźwiak, J Walecki, A Maruszak, J Pniewski, R Lugiewicz, S Filipek, C Zekanowski, M Barcikowska.   

Abstract

A 32-year-old woman diagnosed with very rapidly progressing early-onset Alzheimer's disease (EOAD), age of onset 29 years, and S170F mutation in presenilin 1 gene (PSEN1) is presented. Neuroimaging conducted 2 years after the first symptoms was typical for the advanced stage of Alzheimer's disease (AD), showing cortical brain atrophy, particularly within hippocampus, frontal and temporal cortex. The unaffected parents of the proband are not carriers of the mutation. The paternity was confirmed by microsatellite typing, strongly suggesting de novo origin of S170F mutation. In silico modeling of S170F mutation impact on presenilin 1 (PS1) transmembrane structure indicates that the mutation considerably alters putative interactions of PS1 with other proteins within gamma-secretase complex.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17931627     DOI: 10.1016/j.expneurol.2007.08.016

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  13 in total

1.  Presenilin-1 mutation associated with amnesia, ataxia, and medial temporal lobe T2 signal changes.

Authors:  Tobias C Langheinrich; Charles A J Romanowski; Stephen Wharton; Marios Hadjivassiliou
Journal:  Neurology       Date:  2011-04-19       Impact factor: 9.910

2.  Rare causes of early-onset dystonia-parkinsonism with cognitive impairment: a de novo PSEN-1 mutation.

Authors:  Miryam Carecchio; Marina Picillo; Lorella Valletta; Antonio E Elia; Tobias B Haack; Autilia Cozzolino; Annalisa Vitale; Barbara Garavaglia; Arcangela Iuso; Caterina F Bagella; Sabina Pappatà; Paolo Barone; Holger Prokisch; Luigi Romito; Valeria Tiranti
Journal:  Neurogenetics       Date:  2017-06-29       Impact factor: 2.660

3.  Atypical presentation of a novel Presenilin 1 R377W mutation: sporadic, late-onset Alzheimer disease with epilepsy and frontotemporal atrophy.

Authors:  Barbara Borroni; Andrea Pilotto; Cristian Bonvicini; Silvana Archetti; Antonella Alberici; Andrea Lupi; Massimo Gennarelli; Alessandro Padovani
Journal:  Neurol Sci       Date:  2011-08-06       Impact factor: 3.307

4.  Coding mutations in NUS1 contribute to Parkinson's disease.

Authors:  Ji-Feng Guo; Lu Zhang; Kai Li; Jun-Pu Mei; Jin Xue; Jia Chen; Xia Tang; Lu Shen; Hong Jiang; Chao Chen; Hui Guo; Xue-Li Wu; Si-Long Sun; Qian Xu; Qi-Ying Sun; Piu Chan; Hui-Fang Shang; Tao Wang; Guo-Hua Zhao; Jing-Yu Liu; Xue-Feng Xie; Yi-Qi Jiang; Zhen-Hua Liu; Yu-Wen Zhao; Zuo-Bin Zhu; Jia-da Li; Zheng-Mao Hu; Xin-Xiang Yan; Xiao-Dong Fang; Guang-Hui Wang; Feng-Yu Zhang; Kun Xia; Chun-Yu Liu; Xiong-Wei Zhu; Zhen-Yu Yue; Shuai Cheng Li; Huai-Bin Cai; Zhuo-Hua Zhang; Ran-Hui Duan; Bei-Sha Tang
Journal:  Proc Natl Acad Sci U S A       Date:  2018-10-22       Impact factor: 11.205

5.  De novo deleterious genetic variations target a biological network centered on Aβ peptide in early-onset Alzheimer disease.

Authors:  A Rovelet-Lecrux; C Charbonnier; D Wallon; G Nicolas; M N J Seaman; C Pottier; S Y Breusegem; P P Mathur; P Jenardhanan; K Le Guennec; A S Mukadam; O Quenez; S Coutant; S Rousseau; A-C Richard; A Boland; J-F Deleuze; T Frebourg; D Hannequin; D Campion
Journal:  Mol Psychiatry       Date:  2015-07-21       Impact factor: 15.992

6.  The usefulness of biological and neuroimaging markers for the diagnosis of early-onset Alzheimer's disease.

Authors:  Alessandro Padovani; Nicola Gilberti; Barbara Borroni
Journal:  Int J Alzheimers Dis       Date:  2011-02-21

7.  Familial Alzheimer's Disease Lymphocytes Respond Differently Than Sporadic Cells to Oxidative Stress: Upregulated p53-p21 Signaling Linked with Presenilin 1 Mutants.

Authors:  Joanna Wojsiat; Katarzyna Laskowska-Kaszub; Carolina Alquézar; Emilia Białopiotrowicz; Noemi Esteras; Mykola Zdioruk; Angeles Martin-Requero; Urszula Wojda
Journal:  Mol Neurobiol       Date:  2016-09-19       Impact factor: 5.590

8.  APP, PSEN1, and PSEN2 mutations in early-onset Alzheimer disease: A genetic screening study of familial and sporadic cases.

Authors:  Hélène-Marie Lanoiselée; Gaël Nicolas; David Wallon; Anne Rovelet-Lecrux; Morgane Lacour; Stéphane Rousseau; Anne-Claire Richard; Florence Pasquier; Adeline Rollin-Sillaire; Olivier Martinaud; Muriel Quillard-Muraine; Vincent de la Sayette; Claire Boutoleau-Bretonniere; Frédérique Etcharry-Bouyx; Valérie Chauviré; Marie Sarazin; Isabelle le Ber; Stéphane Epelbaum; Thérèse Jonveaux; Olivier Rouaud; Mathieu Ceccaldi; Olivier Félician; Olivier Godefroy; Maite Formaglio; Bernard Croisile; Sophie Auriacombe; Ludivine Chamard; Jean-Louis Vincent; Mathilde Sauvée; Cecilia Marelli-Tosi; Audrey Gabelle; Canan Ozsancak; Jérémie Pariente; Claire Paquet; Didier Hannequin; Dominique Campion
Journal:  PLoS Med       Date:  2017-03-28       Impact factor: 11.069

Review 9.  New Insights into the Molecular Bases of Familial Alzheimer's Disease.

Authors:  Valeria D'Argenio; Daniela Sarnataro
Journal:  J Pers Med       Date:  2020-04-19

10.  A systematic screening to identify de novo mutations causing sporadic early-onset Parkinson's disease.

Authors:  Celia Kun-Rodrigues; Christos Ganos; Rita Guerreiro; Susanne A Schneider; Claudia Schulte; Suzanne Lesage; Lee Darwent; Peter Holmans; Andrew Singleton; Kailash Bhatia; Jose Bras
Journal:  Hum Mol Genet       Date:  2015-09-11       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.